Navigation Links
FDA Grants Over-The-Counter Clearance to GentleWaves(R) for the First Home Use Light-Based Device to Treat Wrinkles
Date:2/25/2008

Clearance Opens Door For Home Use In The Anti-Aging Market

VIRGINIA BEACH, Va., Feb. 25 /PRNewswire-USNewswire/ -- Light BioScience(R), LLC, the leader in the science of LED (light emitting diode) Photomodulation, announced today that it has become the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for the treatment of periorbital wrinkles. This clearance paves the way for future development of a new anti-aging device to deliver the GentleWaves LED Photomodulation(R) technology directly to the consumer marketplace without a prescription.

Currently used by physicians around the world, GentleWaves has been scientifically proven to reduce the appearance of fine lines and wrinkles through the use of a patented system of pulsating amber-colored LEDs. These LEDs are specifically coded to stimulate collagen production while slowing down collagen breakdown(1). Invented by David H. McDaniel, M.D., director of the Institute of Anti-Aging Research and Assistant Professor of Clinical Dermatology and Plastic Surgery, Eastern Virginia Medical School, Virginia Beach, Va., the GentleWaves LED Photomodulation technology is a novel approach to provide skin rejuvenation without injuring the skin. GentleWaves is non-thermal, non-ablative and has no pain, side effects, or downtime.

"This clearance marks a significant milestone for our company as we continue to demonstrate our leadership in light-based science and break new ground in the medical professional and home use markets," comments Rick Krupnick, Chief Executive Officer of Light BioScience. "The opportunity to develop the first FDA cleared at-home, light-based device to treat wrinkles is just the first step in making this exciting technology more accessible to the public."

The future of GentleWaves is even more promising as its benefits expand beyond the anti-aging arena. Currently the Company is investigating new treatments for wound healing, radiation dermatitis, acne, thinning hair, and ophthalmic disorders.

"Our on-going research reveals that the platform GentleWaves technology has the potential to treat or prevent a wide variety of medical conditions," adds Krupnick. "Light BioScience is committed to investing in research and development so that we can bring these expanded applications to the medical community as well as to the consumer marketplace."

In 2003, Light BioScience created a new way for dermatologists and plastic surgeons to approach anti-aging and skin rejuvenation with the introduction of its flagship product, the GentleWaves LED Photomodulation System. Today, LED technology has become one of the most popular cosmetic treatments offered by doctors and estheticians worldwide.

"GentleWaves LED Photomodulation is a very useful new tool for cosmetic surgeons to reduce wrinkles in a rapid, safe and truly painless manner," explains Dr. McDaniel. "The ability to extend this therapy for use in the home without a reduction in benefits is a significant advancement in treating aging skin. The most exciting part of this development may ultimately be the interest that has been stimulated by the science and theory of Photomodulation discovered during the research and development of the GentleWaves device. Physicians and scientists worldwide are now exploring how very low energy light interacts with not just skin, but all living cells in the body. I expect many new applications for the GentleWaves technology in the future - this is only the beginning of what will be possible for both home and medical light therapies."

Tina Alster, M.D., director of the Washington Institute of Dermatologic and Laser Surgery in Washington, D.C. comments, "GentleWaves(R) offers superior rejuvenation compared to applying Retinoic Acid, but without the potential irritation."

About GentleWaves LED Photomodulation

Quick and convenient for today's fast-paced world, GentleWaves has been clinically proven to reduce fine lines and wrinkles without pain, redness, peeling or downtime. Users spend less than one minute sitting in front of a cascading array of amber colored pulsating lights. Because LED Photomodulation is a non-thermal, photo-biochemical process, it is one of the only technologies now available to safely treat all skin types resulting in noticeably softer, smoother and healthier-looking skin.

About Light BioScience, LLC

Light BioScience, LLC is the leader in the science of Light-Emitting Diodes (LED) Photomodulation, a groundbreaking light-based technology for medical and aesthetic applications. Its flagship product, the GentleWaves LED Photomodulation System, provides a safe and effective nonablative solution to photoaging. This non-thermal, non-invasive technology uses low intensity LEDs at specially calibrated energies to reduce the visible signs of aging and sun-damaged skin.

The company is actively researching other applications of the unique GentleWaves platform technology, including treatment protocols for the control of radiation dermatitis, the treatment of acne, thinning hair, and ophthalmic disorders. Based in Virginia Beach, VA, Light BioScience was founded in 2002 and now has more than 17 issued patents and 60 pending in the U.S.A. and worldwide. GentleWaves is currently used in hundreds of physician offices and medi-spas worldwide and has been clinically tested and shown to be safe and effective.

Dedicated to science and research, the company is continuing it's testing of a variety of new technologies to expand offerings to the medical and consumer markets.

For more information on Light BioScience and its products, visit Light BioScience's website at http://www.lightbioscience.com .

(1) Robert A. Weiss M.D., David H. McDaniel, M.D. Roy G. Geronemus, M.D., Margaret A. Weiss M.D, "Clinical Trial of A Novel Non-Thermal LED Array for Reversal of Photoaging: Clinical, Histologic, and Surface Profilometric Results," Lasers in Surgery Medicine, 2005 and Robert A. Weiss M.D., David H. McDaniel, M.D., Margaret A. Weiss M.D., Roy G. Geronemus, M.D., Karen L. Beasley, Girish M. Munavalli, M.D., Supriya G. Bellew, M.D., "Clinical Experience With Light-Emitting Diode (LED) Photomodulation(R)," The American Society for Dermatologic Surgery, 2005.


'/>"/>
SOURCE Light BioScience, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide
4. USAID Announces First Malaria Communities Program Grants
5. The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations
6. KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
7. FDA Grants Clearance to Langford IC Systems, Inc.
8. Dienst Custom Homes Grants Over 40 Wishes in Three Years
9. United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets
10. PA Health Department Awards Community Primary Care Challenge Grants
11. FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today announced that it will release third-quarter ... October 26, 2017, and will follow with a conference ... 9:00 a.m. Eastern Time. To participate on the call, ... ID is 94093362. ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
(Date:10/4/2017)... 4, 2017  According to the Centers for Disease Control and Prevention ... . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the month. ... health insurance regulations. ... to get a flu shot is by the end of October, according ...
Breaking Medicine Technology: